TNFSF10 and breast carcinoma: Association between the identified TRAIL/TNFSF10 SNPs and CD8+ lymphocyte apoptosis as well as with clinical radiosensitivity endpoints was studied in a set of 113 genotyped breast cancer patients, included in the Co-Ho-RT study [18] (Table 2).